5,6,7,8-四氢吡啶并[3,4-d]嘧啶衍生物的合成

以苄胺为原料,经过取代,缩合,水解,脱保护等步骤,设计合成了一系列新型的5,6,7,8-四氢吡啶并[3,4-d]嘧啶类化合物。通过1H NMR,13C NMR,MS和元素分析确证了其结构。并且对其体外抗肿瘤活性进行了研究,发现该类化合物对乳腺癌细胞MCF-7具有一定的抑制活性,其中化合物10a和10d的抑制活性达到了中效水平。     

Saturated heterocycles,Part 172. Synthesis of 2,6-disubstituted-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine derivatives

The title compounds were synthesized via the addition of methyl acrylate to benzylamine or to α-aminopyridine, which gave the corresponding diesters, e.g. 12 , followed by Dieckmann condensation of the latter to yield the keto-esters 13 , which were condensed with amidines and guanidines, 3, 14 . Removal of the benzyl group by hydrogenolysis and subsequent alkylation of the nitrogen atom at position 6 in the resulting compound 5 , with variation of the substituents on C-2, gave a number of products with potential biological action; some of them gave analgesic and anti-inflammatory effects.     

Synthesis and Cytotoxicity of Novel Diaryl Ureas Containing 2-Amino-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidinyl Group

<正>A series of 2-amino-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidinyl substituted diaryl urea derivatives was designed and synthesized.Their in vitro cytotoxicities against two cancer cell lines(Bel-7402 and A549) were evaluated by standard MTT assay.Six of tested compounds 6,8,10,17,21 and 22 exhibited more potent cytotoxicity superior to sorafenib.The structure activity relationship(SAR) study indicates that 2-amino-5,6,7,8-tetrahydropyrido- [4,3-d]pyrimidinyl group was an option for cytotoxic potency.     

Synthesis of 6-benzyl- and 6-phenethyl-2,4-diamino-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidines

The preparation of ten aralkyl derivatives of 2,4-diamino-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidines ( 6 ) has been accomplished. The title compounds were prepared in a simple one step reaction from 2,4,6-triaminopyrimidine ( 4 ), formaldehyde ( 2 ), and either substituted benzylamines ( 1a-d ) or substituted phenethylamines ( 1e-j ). This modified Mannich reaction has been shown to be a general method for such derivatives. Elemental analysis, ¹H nmr and mass spectral data have confirmed the proposed structures. None of the compounds exhibited either antimalarial or antitrypanosomal activity.     

Synthesis of 2,4-diamino-9H-indeno[2,1-d]pyrimidines

As part of a search for new antifolic, antimalarial, and antitumor agents, a series of 2,4-diamino-9H-indeno[2,1-d]pyrimidines was prepared by condensation of guanidine with substituted 2-alkoxy-3-cyano-1H-indenes. Base-catalyzed cyclization of 1,2-bis(cyanomethyl)benzenes afforded 2-amino-3-cyano-1H-indenes, which were converted into 3-cyano-2-methoxy-1H-indenes by acid hydrolysis and treatment of the resultant 1-cyano-2-indanones with diazomethane. Alternatively, 2-amino-3-cyano-1H-indenes could be transformed directly into 2-ethoxy-3-eyano-1H-indenes by reaction with ethanol and sulfuric acid. The 2,4-diamino-9H-indeno[2,1-d]-pyrimidines represent a new type of planar, tricyclic pyrimethamine analog, in which free rotation of the phenyl and pyrimidine rings is prevented by means of a methylene bridge.     

4-氯-7H-吡咯并[2,3-d]嘧啶与2,4-二氯-7H-吡咯并[2,3-d]嘧啶的合成研究

报道了以廉价易得的丙二酸二乙酯为起始原料,经过α-烷基化、环合、氯化、烯键氧化和SNAr/环化五步反应,高收率地得到目标产物4-氯-7H-吡咯并[2,3-d]嘧啶(6)和2,4-二氯-7H-吡咯并[2,3-d]嘧啶(10)(总收率分别达到45.8%和44.8%)的合成方法,并对中间体和产物的化学结构进行了表征.     

Folate antagonists. 7. Antimalarial,antibacterial, and antimetabolite effects of 2,4-Diamino-6-(benzyl and pyridylmethyl)-5,6,7,8-tetrahydropyrido[4,3-d] pyrimidines

2 Various4-diamino-6-(benzyl and pyridyhnethyl)-5,6,7,8-tetrahydropyrido(4,3-d]pyrimidines (IX) have been synthesized for antimalarial and antibacterial evaluation. Alkylation of 4-amino-3-cyano-1,2,5,6-tetrahydropyridine (VI) with the requisite α-chlorotoluene or picolyl chloride in 2-butanone afforded the corresponding 4-amino-3-eyano-1-(benzyl and pyridvlmethyl)-1,2,5,6-tetraliydropyridines (VIII) (16–73%), which were cyclized to the pyrido[4,3-d]pyrimidines (IX) utilizing guanidine carbonate in dimethylformamide. Alternatively, VI was condensed with guanidine carbonate in ethyl cellosolve to give 2,4-diamino-5,6,7,8-tetrahydropyrido[4,3-d]-pyrimidine (VII) (52%), which upon treatment with the appropriate α-ehlorotoluene in dimethyllormamide gave other 2,4-diamino-6-benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines (IX) (26–27%). Kight compounds were active orally against Plasmodium berghei in mice at doses ranging from 3.9 to 125 mg./kg./day for 6 days (0.6 to 19 times as potent as quinine hydrochloride), while three compounds displayed activity when administered in a single subcutaneous dose of 640 mg./kg. Four substances exhibited in vitro activity against Streptococcus faecalis (MGH-2), normal (UC-76) and drug-resistant (S18713) Staphylococcus aureus, and Streptococcus pyogenes ((1203), with MIC's ranging from > 0.25 to 10 μg./ml. Data on the inhibitory effects of various pyrido[4,3-d]pyrimidines against Streptococcus faecalis R (S. faecium var. durans, ATCC 8043), S. faecalis A (aminopterin, metholrexate-resistant), and Lactobacillus plantarum (ATCC 8014) is summarized.     

Facile Synthesis of 2-Amino-5,6,7,8-tetrahydro-5,7-diarylpyrido[4,3-d]pyrimidin-4-ols

2-Amino-5,6,7,8-tetrahydro-5,7-diarylpyrido[4,3-d]pyrimidin-4-ols were synthesized from various ethyl 2,6-diaryl-4-oxopiperidin-3-carboxylates with guanidine hydrochloride in presence of sodium ethoxide.     

Synthesis of pyrazolo[4,3-d]oxazoles

1-Phenyl-3-methyl-5-pyrazolone-4-oxime reacted with benzylamine, methylamine, methyl- and ethyl ioides to give 3-methyl-1,5-diphenyl-1H-, 3-methyl-1-phenyl-1H- and 3,5-dimethyl-1-phenyl-1H-pyrazolo[4,3-d]oxazoles I, II. The structure of I was elucidated authentically through other routes by interaction of 1-phenyl-3-methyl-4,5-dioxopyrazolone with benzylamine and/or benzaldehyde and ammonium acetate. Various 3-meth-yl-5-aryl-1-phenyl-1H-pyrazolo[4,3-d]oxazoles IV were synthesized by the reaction of 4,5-dioxopyrazolone with aromatic aldehydes in the presence of ammonium acetate. Also, the structure of I was elucidated authentically via other routes by the reaction of 1-phenyl-3-methyl-4-imino-5-pyrazolone with each of benzylcyanide, benzylamine, benzaldehyde and benzalaniline.     

Synthesis,reactions, and antimicrobial activity of some novel pyrazolo[3,4-d]pyrimidine,pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine,and pyrazolo[4,3-e][1,2,4]triazolo[3,4-c]pyrimidine derivatives

Treatment of N-phenyl-substituted benzenecarbo-hydrazonoyl chlorides 1a - d with malononitrile in sodium ethoxide solution gave 5-amino-4-cyanopyrazole derivatives 2 - 5 . Compounds 2 - 5 were converted to formidate derivatives 6 - 9 upon treatment with TEOF in acetic anhydride. The reaction of the latter products 6 - 9 with hydrazine hydrate gave imino-amino derivatives 10 - 13 , which was converted to hydrazino derivatives 14 - 17 by refluxing with hydrazine hydrate. Hydrazino as well as imino-amino derivatives undergo condensation, cyclization, and cycloaddition reactions to give pyrazolo[3,4-d]pyrimidine 18 - 21 , pyrazolo[4,3-e][1,2,4]triazolo-[3,4-c]pyrimidine 22 - 27 , and pyrazolo[3′,4′:4,5]pyrimido[1,6-b][1,2,4]triazine 42 - 44 derivatives. Antimicrobial studies are performed using two Gram-positive bacteria and two Gram-negative bacteria. Data indicated that compounds 5 , 28D , 29B , and 31D are exploring elevated antibacterial effects against all strains tested. Compound 28D is the most promising antibacterial agent against the delicate bacterial strain Bacillus subtilis and Pseudomonas aeruginosa with high effectiveness (low minimum inhibitory concentration [MIC] value) 40 and 60 μg/mL, respectively.     

Pyrimidine derivatives and related compounds. A novel synthesis of pyrimidines,pyrazolo[4,3-d]pyrimidines and isoxazolo[4,3-d] pyrimidine

Benzoylacetonitrile (II) reacted with trichloroacetonitrile (III) to yield the β-amino-β-trichloromethylacrylonitrile IV. Compound IV reacted with hydrazine hydrate to yield 5-amino-4-cyano-3-phenylpyrazole (V) and with 2-aminopyridine to yield the aminopyridine derivative VIII (cf., Chart I). Compound IV reacted with III to yield 2,4-bis(trichloromethyl)-5-cyano-6-phenylpyrimidine (I) which could be converted into a variety of pyrazolo[4,3-d]pyrimidine derivatives by treatment with hydrazine hydrate under a variety of different experimental conditions (cf., Chart II).     

Synthesis of 7-alkyl-2,4-dimethoxy-5-oxo-5H-pyrano[4,3-d]pyrimidines

A convenient synthesis of 7-alkyl-2,4-dimethoxy-5-oxo-5H-pyrano[4,3-d]pyrimidines from methyl 2,4-dimethoxy-6-phenylselenylmethyl (or 6-phenylthiomethyl)-5-pyrimidinecarboxylate with alkylaldehydes is described.     

Synthesis of 6-hydrazino-3,4-dimethyl-1H-pyrazolo[3,4-d]pyrimidine and its application for the construction of a pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidine system

A new representative of heterocyclic hydrazines, viz., 6-hydrazino-3,4-dimethyl-1H-pyrazolo[3,4-d]pyrimidine (3) was synthesized from diacetyl ketene N,S-acetal. A condensation of hydrazine 3 with amide acetals or aldehydes and subsequent cyclization furnished pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidines, whose structure was confirmed by ¹H, ¹³C, and ¹H/¹⁵N HMBC NMR spectroscopy. Reactions of hydrazine 3 with acetylacetone, ethyl acetoacetate, diethyl malonate, and acetic anhydride were studied.     

MgO nanopowders catalyzed synthesis of pyrano[4,3-d]thiazolo[3,2-a]pyrimidine derivatives

A cubic phase of pure MgO nanopowders was prepared in an aqueous solution containing freshly squeezed orange juice with pulp and characterized by X-ray diffraction (XRD), field emission scanning electron microscopy (FE-SEM), energy-dispersive X-ray spectroscopy (EDS), and Fourier transform infrared (FT-IR) spectroscopic techniques. The catalytic potential of MgO nanopowders was evaluated in preparation of pyrano[4,3-d]thiazolo[3,2-a]pyrimidine and chromeno[4,3-d]thiazolo[3,2-a]pyrimidines derivatives using the three simple methods including thermal, ultrasonic irradiation, and high-speed ball milling (HSBM) technique under solvent-free conditions. All products were successfully formed in high yields.     

Synthesis and antitumor activity of novel pyridino[2,3-d]pyrimidine urea derivatives

A series of novel N-(3-((6-bromopyrido[2,3-d]pyrimidin-4-yl)oxy)phenyl)pyrrolidine-1-carboxamide and 1-(3-((6-bromopyrido[2,3-d]pyrimidin-4-yl)oxy)phenyl)-3-propylurea derivatives were synthesized. Their antitumor activities against human breast carcinoma cells (MCF-7) and human colon cancer cells (HCT-116) in vitro were evaluated, using sorafenib as a positive control drug. Anticancer bioassays indicated that several compounds exhibited appreciable anticancer activity against MCF-7 and HCT-116 cells. Particularly, compounds 9g and 8b demonstrated the most significant inhibitory effect against HCT-116 and MCF-7 cells, with inhibition ratios of 25.56% and 26.46%, respectively. Additionally, the synthesized pyridine[2,3-d]pyrimidine derivatives containing a urea group moieties exhibited antitumor activities against MCF-7 and HCT-116 cells in vitro.     

Synthesis of 3,4-diamino-1H-pyrazolo[3,4-d]pyrimidines

The reaction of 4-(amino-substituted)-2-methylthio-6-chloropyrimidine-5-carbonitriles with hydrazine and methylhydrazine was used to synthesize 3, 4-diamino-6-methylthio-1H-pyrazolo[3, 4-d]pyrimidines. It was shown that the formation of pyrazolopyrimidines proceeds through intermediate 6-hydrazinopyrimidine-5-carbonitriles.Department of Organic Chemistry, Vil'nyus University, Vil'nyus 2006. Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 6, pp. 831–836, June, 1996. Original article submitted February 9, 1996.     

Synthesis and antitumor activities of a new series of 4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine derivatives

A new series of 4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine derivatives have been designed and synthesized.The antitumor activities of the target compounds have been evaluated in vitro against two human cancer cell lines including A549 (human alveolar adenocarcinoma cell) and H460 (human lung cancer) by MTT assay.Most of the target compounds exhibited significant antitumor activities against A549 and H460 cancer cell lines.The most potent compound 4-(benzo[d][1,3]dioxol5-yl)-8,9-difluoro-2-(4-methylpiperazin-1-yl)-4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine (CH05) (IC50=0.44 M,3.07 M) was 2.0 and 8.4 times more active than gefitinib (IC50=0.89 M,16.81 M) against A549 and H460 cell lines,respectively.     

Synthesis and antimicrobial activity of some new pyrazole, fused pyrazolo[3,4-d]-pyrimidine and pyrazolo[4,3-e][1,2,4]-triazolo[1,5-c]pyrimidine derivatives

Hydrazonyl bromides 2a,b reacted with active methylene compounds (dibenzoylmethane, acetylacetone, ethyl acetoacetate, phenacyl cyanide, acetoacetanilide, ethyl cyanoacetate, cyanoacetamide and malononitrile) to afford the corresponding 1,3,4,5- tetrasubstituted pyrazole derivatives 5-12a,b. Reaction of 12a,b with formamide, formic acid and triethyl orthoformate give the pyrazolo[3,4-d]pyrimidine, pyrazolo[3,4- d]pyrimidin-4(3H)one and 5-ethoxymethylene-aminopyrazole-4-carbo-nitrile derivatives 13-15a,b, respectively. Compounds 15 a,b reacted with benzhydrazide and hydrazine hydrate to afford pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine and [4-iminopyrazolo- [3,4-d]pyrimidin-5-yl]amine derivatives 16 a,b and 17 a,b. Reactions of compounds 17 a,b with triethyl orthoformate and carbon disulfide give the corresponding pyrazolo[4,3-e]- [1,2,4]triazolo[1,5-c]pyrimidine derivatives 18a,b and 19 a,b, respectively.     

Synthesis of triazolo[4,3-d], tetrazolo[1,5-a] -and quinazolino[3,2-d] [1,4] benzodiazepines

Treatment of 5-methylmercapto-1,4-benzodiazepine (I) with hydrazine hydrate gave the 5-hydrazino derivative (II, R = H) which, in turn, was conveniently cyclized to the title compounds. Another method for the synthesis of triazolo [4,3-d] [1,4] benzodiazepines (III) is also described.